首页 正文

Responders and non-responders to romosozumab treatment

{{output}}
Introduction: Romosozumab is an anti-sclerostin antibody drug with potent bone formation-promoting and bone resorption-inhibiting properties. It enhances bone mineral density and has a novel effect in preventing fractures. Howeve... ...